Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

BREAKING: Primate Bio-Samples Become Neuroscience's New Gold Rush as Alzheimer's Trials Accelerate

Creative Biolabs stands out in the race as brain diseases fuel a surge in demand for NHP biospecimens—cerebrospinal fluid (CSF)—functioning as the gold standard for validating next-gen brain therapies.

A landmark study about gene therapy recently reported in Nature Biotechnology indicating 27% cognitive improvement in Alzheimer's mice using circular RNA has set labs scrambling for high-quality NHP samples that are firmly determined as the gold standard for bridging preclinical breakthroughs to human trials.

PR and Communications Manager

PR and Communications Manager
Full time
Reports to: Head of Marketing and Communications
Job location: Xampla HQ, Cambridge Science Park (hybrid)

Introduction to Xampla
Xampla is a groundbreaking materials technology company unlocking the power of natural plant polymers for a range of industries and applications, from plastic-free alternatives in packaging to high-performance encapsulation.

Source BioScience acquires Cambridge Clinical Laboratories

Cambridge, UK, 10 April 2025: Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL), a leading Cambridge-based provider of clinical, personalised healthcare testing services. The acquisition bolsters the Company’s clinical diagnostics portfolio by leveraging the expertise of the CCL team and new state-of-the-art clinical lab facilities at Vision Park in Cambridge, providing streamlined testing services for both preclinical and clinical research.

Coulter Partners strengthens leadership at iOnctura with placement of Board Chair

London, April 10, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for iOnctura and is pleased to announce the placement of Dr. Mark Velleca as Chair of the Board of Directors.

iOnctura is a clinical-stage precision oncology company combating neglected and hard-to-treat cancers with a pipeline of first-in-class small molecules.

Cancer Research Horizons partners with Histofy to develop AI-based tools for the personalised treatment of colorectal cancer

Cancer Research Horizons, the innovation arm of Cancer Research UK, has announced a collaboration with Histofy, a leader in AI-driven histopathology solutions, to develop tools that predict how colorectal cancer patients respond to different treatment options using the multi-modal S:CORT dataset.

Subscribe to